Company intelligence / Profile preview

Readout Capital

Ownership: Private
Development stage: Other

Overview

Readout Capital is a private investment management company specializing in venture capital for the biotechnology and pharmaceutical sectors. It is led by experienced investors with a focus on identifying undervalued or overlooked companies within life sciences. The company does not develop drugs or own therapeutic pipelines itself but instead invests capital into other firms operating across various modalities and indications within healthcare. There are no public details about its portfolio companies, financials, or specific geographic focus beyond its general emphasis on biotech/pharma value opportunities.

Industry: Investors

Beyond the preview

Go deeper on Readout Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Readout Capital.

Explore the full profile